Truist Securities Maintains Buy on PROCEPT BioRobotics, Lowers Price Target to $55
Truist Securities analyst Richard Newitter maintains PROCEPT BioRobotics (NASDAQ:PRCT) with a Buy and lowers the price target from $58 to $55.
Goldman Sachs Maintains Neutral on PROCEPT BioRobotics, Raises Price Target to $44
Goldman Sachs analyst Amit Hazan maintains PROCEPT BioRobotics (NASDAQ:PRCT) with a Neutral and raises the price target from $39 to $44.
Keybanc Maintains Overweight on PROCEPT BioRobotics, Raises Price Target to $48
Keybanc analyst Matthew Mishan maintains PROCEPT BioRobotics (NASDAQ:PRCT) with a Overweight and raises the price target from $47 to $48.
Earnings Scheduled For November 3, 2022
Companies Reporting Before The Bell
• Hyatt Hotels (NYSE:H) is estimated to report quarterly earnings at $0.28 per share on revenue of $1.45 billion.
Truist Securities Initiates Coverage On PROCEPT BioRobotics with Buy Rating, Announces Price Target of $58
Truist Securities analyst Richard Newitter initiates coverage on PROCEPT BioRobotics (NASDAQ:PRCT) with a Buy rating and announces Price Target of $58.
Why ShiftPixy Surged Around 177%; Here Are 71 Biggest Movers From Yesterday
Gainers
ShiftPixy, Inc. (NASDAQ: PIXY) shares surged 176.5% to close at $31.00 on Thursday after the company announced plans to spin-off ShiftPixy Labs and dividend its digital securities to shareholders.
Wells Fargo Initiates Coverage On PROCEPT BioRobotics with Overweight Rating, Announces Price Target of $49
Wells Fargo analyst Nathan Treybeck initiates coverage on PROCEPT BioRobotics (NASDAQ:PRCT) with a Overweight rating and announces Price Target of $49.
Earnings Scheduled For August 4, 2022
Companies Reporting Before The Bell
• Toyota Motor (NYSE:TM) is projected to report earnings for its first quarter.